Cyclosporine in chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial
2006
Background Treatment of severe recalcitrant chronic idiopathic urticaria (CIU) is difficult. Objective To assess the efficacy and safety of oral cyclosporin A (CsA) in CIU. Methods The response to CsA was evaluated in 99 CIU patients with a double-blind, randomized, three-armed study: 16-week CsA, 8-week CsA +8-week placebo, and 16-week placebo. All patients received cetirizine throughout the study period and were followed-up after 8 weeks. Results Fewer therapeutic failures occurred with 16-week CsA (n = 3) than with placebo (n = 11) and 8-week CsA (n = 8). After 8 and 16 weeks, symptom scores significantly improved in both CsA groups over with placebo. Two patients discontinued because of hypertension. Limitations During the study period, CsA was not administered at a constant dose; from day 28 the daily dose was 3 mg/kg, which is likely to be less effective and better tolerated than higher dosages. Conclusion CsA in addition to background therapy with cetirizine may be useful in the treatment of CIU.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
16
References
149
Citations
NaN
KQI